Barclays PLC Genocea Biosciences, Inc. Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.01 - $1.38 $0 - $4	3 New	3 $0
Q2 2021 Aug 13, 2021	SELL	$2.06 - $2.82 $3,631 - $4,971	-1,763 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.35 - $4.01 $4,143 - $7,069	1,763 New	1,763 $5,000
Q3 2020 Nov 12, 2020	SELL	$1.81 - $5.53 $101 - $309	-56 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.66 - $3.06 $92 - $171	56 New	56 $0
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $41,539 - $58,298	-14,324 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $49,704 - $96,114	14,324 New	14,324 $58,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.